Tumor-associated angiogenesis and lymphangiogenesis correlate with progression of intrahepatic cholangiocarcinoma

American Journal of Gastroenterology

Volumn 105, Issue 5, 2010, Pages 1123-1132

  Thelen, Armin ^a   Scholz, Arne ^b   Weichert, Wilko ^b   Wiedenmann, Bertram ^b   Neuhaus, Peter ^b   Gener, Reinhard ^a   Benckert, Christoph ^a   Jonas, Sven ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CD31 ANTIBODY; MONOCLONAL ANTIBODY D2-40; UNCLASSIFIED DRUG;

ADULT; AGED; ANGIOGENESIS; ARTICLE; BILE DUCT CARCINOMA; CANCER GROWTH; CANCER RECURRENCE; CANCER SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; LYMPHANGIOGENESIS; MAJOR CLINICAL STUDY; MALE; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; BIOPSY, NEEDLE; CHOLANGIOCARCINOMA; COHORT STUDIES; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIERS ESTIMATE; LYMPHANGIOGENESIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; PROBABILITY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; SURVIVAL RATE;

EID: 77951974242     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2009.674     Document Type: Article

References (35)

1. West J, Wood H, Logan RF et al. Trends in the incidence of primary liver and biliary tract cancers in England and Wales 1971-2001. Br J Cancer 2006; 94: 1751-1758
2. Patel T. Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology 2001; 33: 1353-1357
3. Endo I, Gonen M, Yopp AC et al. Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome aft er resection. Ann Surg 2008; 248: 84-96.
4. Hammill CW, Wong LL. Intrahepatic cholangiocarcinoma: a malignancy of increasing incidence. J Am Coll Surg 2008; 207: 594-603.
5. Tortora G, Ciardiello F, Gasparini G. Combined targeting of EGFRdependent and VEGF-dependent pathways: rationale, preclinical studies and clinical applications. Nat Clin Pract Oncol 2008; 5: 521-530
6. Rhee J, Hoff PM. Angiogenesis inhibitors in the treatment of cancer. Expert Opin Pharmacother 2005; 6: 1701-1711
7. Benckert C, Jonas S, Cramer T et al. Transforming growth factor beta 1 stimulates vascular endothelial growth factor gene transcription in human cholangiocellular carcinoma cells. Cancer Res 2003; 63: 1083-1092
8. Shirabe K, Shimada M, Tsujita E et al. Prognostic factors in node-negative intrahepatic cholangiocarcinoma with special reference to angiogenesis. Am J Surg 2004; 187: 538-542
9. Stacker SA, Caesar C, Baldwin ME et al. VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nature Med 2001; 7: 186-191
10. Skobe M, Hawighorst T, Jackson DG et al. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 2001; 7: 192-198
11. Duff SE, Li C, Jeziorska M et al. Vascular endothelial growth factors C and D and lymphangiogenesis in gastrointestinal tract malignancy. Br J Cancer 2003; 89: 426-430
12. van Iterson V, Leidenius M, von Smitten K et al. VEGF-D in association with VEGFR-3 promotes nodal metastasis in human invasive lobular breast cancer. Am J Clin Pathol 2007; 128: 759-766
13. Das S, Skobe M. Lymphatic vessel activation in cancer. Ann N Y Acad Sci 2008; 1131: 235-241
14. Sobin LH, Wittekind CH. TNM Classifi cation of Malignant Tumours. 6Thedn. John Wiley & Sons Ltd.: West Sussex, 2002.
15. Jonas S, Thelen A, Benckert C et al. Extended liver resection for intrahepatic cholangiocarcinoma: a comparison of the prognostic accuracy of the fi ft h and sixTheditions of the TNM classifi cation. Ann Surg 2009; 249: 303-309
16. Yang ZF, Poon RT. Vascular changes in hepatocellular carcinoma. Anat Rec (Hoboken) 2008; 291: 721-734
17. Ribatti D, Vacca A, Nico B et al. Angiogenesis and anti-angiogenesis in hepatocellular carcinoma. Cancer Treat Rev 2006; 32: 437-444
18. Jonas S, Bechstein WO, Steinm ü ller T et al. Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology 2001; 33: 1080-1086
19. Imamura H, Matsuyama Y, Tanaka E et al. Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma aft er hepatectomy. J Hepatol 2003; 38: 200-207
20. Thelen A, Scholz A, Benckert C et al. Microvessel density correlates with lymph node metastases and prognosis in hilar cholangiocarcinoma. J Gastroenterol 2008; 43: 959-966
21. Patel T. Cholangiocarcinoma. Nat Clin Pract Gastroenterol Hepatol 2006; 3: 33-42.
22. Bhuiya MR, Nimura Y, Kamiya J et al. Clinicopathologic studies on perineural invasion of bile duct carcinoma. Ann Surg 1992; 215: 344-349
23. Ouchi K, Suzuki M, Hashimoto L et al. Histologic fi ndings and prognostic factors in carcinoma of the upper bile duct. Am J Surg 1989; 157: 552-556
24. M ö bius C, Demuth C, Aigner T et al. Evaluation of VEGF-A expression and microvascular density as prognostic factors in extrahepatic cholangiocarcinoma. Eur J Surg Oncol 2007; 33: 1025-1029
25. Giatromanolaki A, Sivridis E, Koukourakis MI et al. Prognostic role of angiogenesis in operable carcinoma of the gallbladder. Am J Clin Oncol 2002; 25: 38-41.
26. da Rocha AO, Coutinho LM, Schall JG. The prognostic value of angiogenesis by Chalkley counting in gallbladder carcinoma. Hepatogastroenterology 2009; 56: 34-38
27. Zhi YH, Liu RS, Song MM et al. Cyclooxygenase-2 promotes angiogenesis by increasing vascular endothelial growth factor and predicts prognosis in gallbladder carcinoma. World J Gastroenterol 2005; 11: 3724-3728
28. Thelen A, Scholz A, Benckert C et al. VEGF-D promotes tumor growth and lymphatic spread in a mouse model of hepatocellular carcinoma. Int J Cancer 2008; 122: 2471-2481
29. Thelen A, Jonas S, Benckert C et al. Tumor-associated lymphangiogenesis correlates with prognosis aft er resection of human hepatocellular carcinoma. Ann Surg Oncol 2009; 16: 1222-1230
30. Thelen A, Scholz A, Benckert C et al. Tumor-associated lymphangiogenesis correlates with lymph node metastases and prognosis in hilar cholangiocarcinoma. Ann Surg Oncol 2008; 15: 791-799
31. You DD, Lee HG, Paik KY et al. What is an adequate extent of resection for T1 gallbladder cancers? Ann Surg 2008; 247: 835-838
32. Nakashima T, Kondoh S, Kitoh H et al. Vascular endothelial growth factor-C expression in human gallbladder cancer and its relationship to lymph node metastasis. Int J Mol Med 2003; 11: 33-39
33. He Y, Kozaki K, Karpanen T et al. Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling. J Natl Cancer Inst 2002; 94: 819-825
34. Pytowski B, Goldman J, Persaud K et al. Complete and specifi c inhibition of adult lymphatic regeneration by a novel VEGFR-3 neutralizing antibody. J Natl Cancer Inst 2005; 97: 14-21.
35. Ahmed SI, Th omas AL, Steward WP. Vascular endothelial growth factor (VEGF) inhibition by small molecules. J Chemother 2004; 16: 59-63.